FAQ

CDP323

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
01220132015

Related topics

Related topics

2 relations

Broader (1)

Phenylalanine
analogs & derivatives

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
CDP323
Phenylalanine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist.
CT7758, a carboxylate containing α4β1/α4/β7 integrin antagonist, was characterized for its pharmacokinetic profile in various in… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
Dmd064436 1381..1391
CT7758, a carboxylate containing a4b1/a4/b7 integrin antagonist, was characterized for its pharmacokinetic profile in various in… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
2014
2014
In vitro hydrolysis and transesterification of CDP323, an α4β1/α4β7 integrin antagonist ester prodrug.
We identified the enzyme(s) involved in the hydrolysis of the ethyl ester prodrug CDP323 (C28H29BrN403) and characterized its… (More)
Is this relevant?
2013
2013
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study
BACKGROUND Lymphocyte inhibition by antagonism of α4 integrins is a validated therapeutic approach for relapsing multiple… (More)
  • table 8:1
  • table 8:1
  • table 10:1
  • table 11:1
  • table 11:2
Is this relevant?
2013
2013
Dmd054049 153..161
We identified the enzyme(s) involved in the hydrolysis of the ethyl ester prodrug CDP323 (C28H29BrN403) and characterized its… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?